Exosomes Overexpressing CD-24

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NameExosomes Overexpressing CD-24
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCytokines inhibitors
TargetsCytokines
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNano24med
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNano24med
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A